Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-01-03
1996-07-23
Wu, Shean C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
564 57, A61K 3121, C07C27526
Patent
active
055389970
ABSTRACT:
The invention relates to compounds of formula I ##STR1## wherein the substituents have various significances. They can be prepared by conventional methods, e.g. coupling, substitution, deprotection or protection reactions.
They possess interesting pharmacological properties and are thus indicated for use in the treatment of retroviral infections, particularly as HIV proteinase inhibitors.
REFERENCES:
patent: 4661473 (1987-04-01), Boger et al.
J. Am. Chem. Soc. 1991, 113, 9382-9384.
J. Med. Chem. 1992, 35, 3080-3081.
Praeklinische Forschung (2 pages) 206th Am. Chem. Soc. Nat'l. Mtg. Aug. 22-27, 1993; Chicago
Antimicrobial Agents and Chemotherapy, Nov. 1991 p. 2209-2214.
Structure and Function of the Aspartic Proteinases and pp. 395-405.
Billich Andreas
Charpiot Brigitte
Ettmayer Peter
Gstach Hubert
Lehr Philipp
Honor Robert S.
Kassenoff Melvyn M.
McGovern Thomas O.
Sandoz Ltd.
Wu Shean C.
LandOfFree
2,4-diamino-3-hydroxycarboxylic acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,4-diamino-3-hydroxycarboxylic acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,4-diamino-3-hydroxycarboxylic acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-713395